Signaling Pathways - Ca2 -ATPases - p53-MDM2 interaction - Vitamin D receptors (VDRs) - Topoisomerases
清除全部
-
B4745 (S)-10-Hydroxycamptothecin中文名: 羟喜树碱Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂 -
B7382 Ellipticine中文名: 玫瑰树碱，椭圆玫瑰树碱Target: TopoisomerasesSummary: DNA拓扑异构酶II抑制剂 -
B6614 Thapsigargin1 Citation中文名: 毒胡萝卜素Target: Ca2 -ATPasesSummary: 肌质网状Ca2+-ATP酶抑制剂 -
B2295 Pirarubicin1 Citation中文名: 吡柔比星Target: TopoisomerasesSummary: 拓扑异构酶II抑制剂，蒽环类抗生素 -
B1801 Norfloxacin中文名: 诺氟沙星Target: TopoisomerasesSummary: 拓扑异构酶抑制剂 -
B2140 Calcifediol中文名: 骨化二醇Target: Vitamin D receptors (VDRs)Summary: 维生素D3的主要循环形式 -
B2091 Doxercalciferol1 Citation中文名: 度骨化醇Target: Vitamin D receptors (VDRs)Summary: 维生素D受体激活剂 -
B2293 Irinotecan HCl Trihydrate中文名: 盐酸依立替康三水合物Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂 -
B2290 Beta-Lapachone中文名: β-拉帕醌Target: TopoisomerasesSummary: 选择性DNA拓扑异构酶I抑制剂 -
A8804 AMG2322 CitationTarget: p53-MDM2 interactionSummary: p53-MDM2抑制剂